Salarius Pharmaceuticals Inc.
01/17/2025 | Press release | Distributed by Public on 01/17/2025 16:17
Private Placement (Form 8-K)
Item 2.02 Results of Operations and Financial Condition.
On January 17, 2025, Salarius Pharmaceuticals, Inc. (the "Company") disclosed that, as of December 31, 2024, the Company estimates that its cash and cash equivalents totaled $2.4 million, which were held in bank deposit accounts and a money market account. Such amounts are preliminary, have not been audited and are subject to change upon completion of the Company's audited financial statements for the year ended December 31, 2024. Additional information and disclosures would be required for a more complete understanding of the Company's financial position and results of operations as of December 31, 2024.